Replies to post #124702 on Biotech Values

[genisi]

Is it worth my looking into

Only if you have Peyronie’s disease :-)
Seriously, I don't know much but as far as I can tell Xiaflex's data in Dupuytren's contracture were good. I don't know the market size and why sales are weak. Phase IIb data in Peyronie’s were mixed, but I see that phase III design is different, so probably a better chance to show stat-sig improvement over placebo.